| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 02/24/2011 | CA2771441A1 Antibodies for the detection of integrin complexes in ffpe material |
| 02/24/2011 | CA2771303A1 Enhanced efficiency of induced pluripotent stem cell generation from human somatic cells |
| 02/24/2011 | CA2771277A1 Cloning and expression of arnox protein transmembrane 9 superfamily (tm9sf), methods and utility |
| 02/24/2011 | CA2771020A1 Simplified storage of integrated systems |
| 02/24/2011 | CA2770341A1 Riboflavin based aerosol and use as placebo in trials |
| 02/24/2011 | CA2769998A1 Imatinib immunoassay |
| 02/24/2011 | CA2769427A1 Anti-cmet antibody and its use for the detection and the diagnosis of cancer |
| 02/24/2011 | CA2768640A1 Apolipoprotein l-i variants and their use |
| 02/23/2011 | EP2287760A1 Method for managing the remote electronic issue of blood units |
| 02/23/2011 | EP2287701A1 A dynamic and tracing system for test environment that contains the amount of formaldehyde and voc released from artifical board |
| 02/23/2011 | EP2287623A1 Microanalysis chip adhesive sheet, microanalysis chip, and manufacturing method thereof |
| 02/23/2011 | EP2287619A1 Detection of foetal cells from maternal blood |
| 02/23/2011 | EP2287618A2 Method for diagnosing neuro-degenerative disease |
| 02/23/2011 | EP2287617A2 Method for diagnosing neuro-degenerative disease |
| 02/23/2011 | EP2287616A1 Method of using cytokine assays to diagnose, treat, and evaluate systemic lupus erythematosus |
| 02/23/2011 | EP2287615A1 Apoptosis sensitivity to APO2L/TRAIL by testing for GALNAC-T14 expression in cells/tissues |
| 02/23/2011 | EP2287614A1 Semiconductor nanocrystal probes for biological applications |
| 02/23/2011 | EP2287613A2 Detection, monitoring and treatment of cancer |
| 02/23/2011 | EP2287612A1 Quantitative analysis of a biological sample of unknown quantity |
| 02/23/2011 | EP2287611A1 Detecting method and dielectric particle containing magnetic material employed in the detecting method |
| 02/23/2011 | EP2287610A1 Thiol-modified surface immobilization article and method |
| 02/23/2011 | EP2287609A1 Method for production of insoluble carrier particle, insoluble carrier particle, measurement reagent, sample analysis tool, and immunology turbidimetric method |
| 02/23/2011 | EP2287608A2 Biomarkers for cardiovascular side-effects induced by cox-2 inhibitory compounds |
| 02/23/2011 | EP2287607A1 Method for quantification of antigen-specific canine or human ige |
| 02/23/2011 | EP2287606A1 Method and assay for glycosylation pattern detection related to cell state |
| 02/23/2011 | EP2287605A1 Simplified magazining of integrated systems |
| 02/23/2011 | EP2287604A1 Method for examination of alzheimer s disease |
| 02/23/2011 | EP2287602A1 Use of ionic matrices for MALDI mass spectrometry analysis of tissue sections |
| 02/23/2011 | EP2287599A1 Gas Sensor |
| 02/23/2011 | EP2287591A2 Method and device for determining the concentration of NO2 in gas mixtures |
| 02/23/2011 | EP2287589A1 Skin-substitutive membrane, metal mold, and method of evaluating agent for external application onto skin |
| 02/23/2011 | EP2287339A1 Methods and kits to detect hereditary angioedema type III |
| 02/23/2011 | EP2287330A1 Biocatalytic Solgel Microarrays |
| 02/23/2011 | EP2287316A1 Antigenic polypeptides |
| 02/23/2011 | EP2287315A1 Streptococcus pyogenes antigens |
| 02/23/2011 | EP2287314A1 Streptococcus pyogenes antigens |
| 02/23/2011 | EP2287313A1 Streptococcus pyogenes antigens |
| 02/23/2011 | EP2287312A1 Streptococcus pyogenes antigens |
| 02/23/2011 | EP2287311A1 Streptococcus pyogenes antigens |
| 02/23/2011 | EP2287310A1 Compositions and methods of use for mgd-csf in disease treatment |
| 02/23/2011 | EP2287201A2 RS7 antibodies |
| 02/23/2011 | EP2287200A1 Method for generating monoclonal antibodies that recognize progenitor cells |
| 02/23/2011 | EP2287199A2 Anti-alpha V beta 6 antibodies |
| 02/23/2011 | EP2287198A2 Anti-alpha V beta 6 antibodies |
| 02/23/2011 | EP2287197A1 Anti-cMET antibody and its use for the detection and the diagnosis of cancer |
| 02/23/2011 | EP2287195A2 Pan-KIR2DL NK-receptor antibodies and their use in diagnostik and therapy |
| 02/23/2011 | EP2287192A1 Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis |
| 02/23/2011 | EP2287191A2 Human igm antibodies with the capability of inducing remyelination, and diagnostic and therapeutic uses thereof particularly in the central nervous system |
| 02/23/2011 | EP2287190A2 Human igm antibodies with the capability of inducing remyelination, and diagnostic and therapeutic uses thereof particularly in the central nervous system |
| 02/23/2011 | EP2287186A1 Nucleic acid and corresponding protein entitled STEAP-1 useful in treatment and detection of cancer |
| 02/23/2011 | EP2287185A2 High affinity TCR proteins and methods |
| 02/23/2011 | EP2287182A2 Differential in tumour gene products and use of same |
| 02/23/2011 | EP2287181A2 Differential in tumour gene products and use of same |
| 02/23/2011 | EP2287179A2 Increased bacillus YweA expression |
| 02/23/2011 | EP2287177A2 Streptococcus agalactiae antigens I + II |
| 02/23/2011 | EP2286918A1 Method for analyzing plurality of liquid samples |
| 02/23/2011 | EP2286844A2 Antibody-drug conjugates and methods |
| 02/23/2011 | EP2286829A1 Drug, dental material, and screening method |
| 02/23/2011 | EP2286720A1 Biological fluid constituent sampling and measurement devices and methods |
| 02/23/2011 | EP2286245A2 Means and methods for assessing increased peroxisomal proliferation |
| 02/23/2011 | EP2286244A1 Modulators of monoglyceride lipase in the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoea |
| 02/23/2011 | EP2286243A1 Pctp modulators in the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoea |
| 02/23/2011 | EP2286242A1 Modulators of acetyl-coenzyme a acyltransferase 1 or 2 in the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoea |
| 02/23/2011 | EP2286241A1 Modulators of isovaleryl-coenzyme a dehydrogenase in the treatment of acne, of seborrhoeic dermatitis or of hyper seborrhoea |
| 02/23/2011 | EP2286240A1 Biomarker for osteoarthritis and/or other ageing-related diseases, and use thereof |
| 02/23/2011 | EP2286239A1 Total plasma fvi i /fvi ia levels as indicators of pre-eclampsia of pregnant females |
| 02/23/2011 | EP2286238A1 Methods of distinguishing between glutamine formed by cataplerosis or proteolysis |
| 02/23/2011 | EP2286237A1 Mass spectrometric analysis |
| 02/23/2011 | EP2286236A2 Means and methods for assessing liver toxicity |
| 02/23/2011 | EP2286235A1 Means and methods for assessing liver enzyme induction |
| 02/23/2011 | EP2286234A1 Novel au / ag core-shell composite useful for biosensor |
| 02/23/2011 | EP2286233A2 Methods and kits for the diagnosis of rheumatoid arthritis |
| 02/23/2011 | EP2286232A1 Methods for the identification of parp interacting molecules and for purification of parp proteins |
| 02/23/2011 | EP2286231A1 Hematopoietic cells expressing the protein susd3 and ligands for the protein susd3 |
| 02/23/2011 | EP2286230A2 Mycobacterial infections |
| 02/23/2011 | EP2286229A1 Products and analytical method |
| 02/23/2011 | EP2286228A2 Droplet actuator devices and methods for manipulating beads |
| 02/23/2011 | EP2286227A1 Method for detecting chemical or biological species and electrode arrangement therefor |
| 02/23/2011 | EP2286226A2 Serum markers for type ii diabetes mellitus |
| 02/23/2011 | EP2286225A1 Method for detecting a virus |
| 02/23/2011 | EP2286224A1 Method for improving cardiovascular risk profile of cox inhibitors |
| 02/23/2011 | EP2286223A2 Arrayed detector system for measurement of influenza immune response |
| 02/23/2011 | EP2286222A1 Use of a monophosphate ester of a phthalein compound as a substrate for tartrate-resistant acid phosphatase b5 (trap 5b) |
| 02/23/2011 | EP2286221A2 Methods for assaying compounds or agents for ability to displace potent ligands of hematopoietic prostaglandin d synthase |
| 02/23/2011 | EP2286220A2 Methods for predicting patient response to modulation of the co-stimulatory pathway |
| 02/23/2011 | EP2286219A2 Assays for performance of organisms in phenotrons |
| 02/23/2011 | EP2286217A1 Single molecule loading methods and compositions |
| 02/23/2011 | EP2286208A1 A composite material for use in a sensing electrode for measuring water quality |
| 02/23/2011 | EP2286026A2 Local tension generating air stabilization system for web products |
| 02/23/2011 | EP2285987A2 Modulators of mcam in the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoea |
| 02/23/2011 | EP2285986A1 Adfp modulators in the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoea |
| 02/23/2011 | EP2285983A1 Use of runx3 and mir-532-5p as cancer markers and therapeutic targets |
| 02/23/2011 | EP2285828A1 Polypeptides involved in the neuroregeneration-promoting properties of olfactory ensheathing glia |
| 02/23/2011 | EP2285827A1 Peptides and uses thereof |
| 02/23/2011 | EP2285420A2 Polyelectrolyte with positive net charge for use as medicament and diagnostic for cancer |
| 02/23/2011 | EP2285399A2 Egf-a domain-mediated modulation of pcsk9 for treating lipid disorders |
| 02/23/2011 | EP2195639B1 Single-cell label-free assay |
| 02/23/2011 | EP2095129B1 Direct mass spectrometric analysis of self-aggregates of therapeutic proteins |
| 02/23/2011 | EP1920250B1 Analyte test system using non-enzymatic analyte recognition elements |
| 02/23/2011 | EP1917530B1 Use of an endoplasmin fragment and derivatives thereof as a biomarker for colorectal adenoma and/or carcinoma; method for detection and test system |